Drug & Device Safety Atlas

FDA drug recalls · openFDA

Is NOREPINEPHRINE BITARTRATE recalled?

The FDA has recorded 2 recalls of NOREPINEPHRINE BITARTRATE (2023–2024) , recalled under brand like NOREPINEPHRINE BITARTRATE. 1 still ongoing.

0
Class I (most serious)
1
Class II
1
Class III
1
ongoing

A recall doesn't mean your pills are affected

Drug recalls are issued by lot (specific batches, identified by lot numbers / NDC) — not for every bottle of NOREPINEPHRINE BITARTRATE ever made. To know if yours is involved, match the lot codes on the recall below against your bottle, or ask your pharmacist. Do not stop a prescribed medication because of a recall without talking to your pharmacist or prescriber — stopping can be more dangerous than the recall. The Class is the FDA's risk judgment (Class I = reasonable probability of serious harm or death), not a measurement that harm occurred; most recalls are voluntary and Class II/III.

Why it was recalled

Incorrect product concentration on the overwrap label: The overwrap label incorrectly identified the product strength as 1
Failed Impurities/Degradation Specifications: Above the specification limits yielded for related substance norepinephrin 1

The recalls

Class I and ongoing recalls first. Tap a recall for its full record and lot detail.

RECORDED — these are the FDA's published recall enforcement records (openFDA), grouped by the generic drug name. Scope: drug recalls the FDA recorded with a generic name; device recalls and recalls without a generic name are in the full recall browse. "Ongoing" reflects openFDA's last-published status — confirm current status and your lot at the FDA recall database. This page informs and routes; it is not medical advice.

Machine-readable: JSON-LD · Markdown